Piermont Valley Acquisition Corp
Status: Live Deal
U=S+W/2
W=S@11.50
| IPO Proceeds, $M | $230.00M |
|---|---|
| IPO Date | Dec 1, 2021 |
| CEO | Wei Qian |
| Left Lead | Barclays |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 15 + 3 + 9 + 12 + 12 + 12 |
| IPO Sector | Consumer ▶ |
| IPO Geography | Global |
| Target Company | Tigerless Health |
| Deal Announced | Apr 20, 2026 |
| Deal Size, $M | TBD |
| Deal Sector | Financial |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | Mar 2, 2026 |
CMCAF
CMCAU
CMCAW
| Price | $2.60 |
|---|---|
| Last closing price | $2.60 |
| H/L, today | $2.60 / $2.60 |
| Volume, today | 12 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.